Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Heska Corporation stock (HSKA)

Buy Heska Corporation stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Heska Corporation is a medical devices business based in the US. Heska Corporation shares (HSKA) are listed on the NASDAQ and all prices are listed in US Dollars. Heska Corporation employs 808 staff and has a trailing 12-month revenue of around $254.9 million.

Our top picks for where to buy Heska Corporation stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you fund a new account within 30 days
  • Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%

How to buy Heska Corporation stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – HSKA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Heska Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Product USFST Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Finder score
Stocks, ETFs
$0
$0
N/A
Earn up to $300
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Finder score
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Heska Corporation stock price (NASDAQ: HSKA)

Use our graph to track the performance of HSKA stocks over time.

Heska Corporation shares at a glance

Information last updated 2023-08-06.
52-week range$0.00 - $0.00
50-day moving average $117.55
200-day moving average $87.11
Wall St. target price$130.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.92

Is it a good time to buy Heska Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Heska Corporation stock undervalued or overvalued?

Valuing Heska Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Heska Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Heska Corporation's PEG ratio

Heska Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.53. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Heska Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Heska Corporation financials

Revenue TTM $254.9 million
Gross profit TTM $111.2 million
Return on assets TTM -2.51%
Return on equity TTM -4.73%
Profit margin -7.86%
Book value $38.26
Market Capitalization $1.3 billion

TTM: trailing 12 months

Heska Corporation share dividends

We're not expecting Heska Corporation to pay a dividend over the next 12 months.

Have Heska Corporation's shares ever split?

Heska Corporation's shares were split on a 1:10 basis on 29 December 2010 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Heska Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Heska Corporation shares which in turn could have impacted Heska Corporation's share price.

Heska Corporation share price volatility

Over the last 12 months, Heska Corporation's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

HSKA.US volatility(beta: 1.6)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Heska Corporation's is 1.5992. This would suggest that Heska Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Heska Corporation overview

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995.

Frequently asked questions

null
What percentage of Heska Corporation is owned by insiders or institutions?
Currently 6.456% of Heska Corporation shares are held by insiders and 87.545% by institutions.
How many people work for Heska Corporation?
Latest data suggests 808 work at Heska Corporation.
When does the fiscal year end for Heska Corporation?
Heska Corporation's fiscal year ends in December.
Where is Heska Corporation based?
Heska Corporation's address is: 3760 Rocky Mountain Avenue, Loveland, CO, United States, 80538
What is Heska Corporation's ISIN number?
Heska Corporation's international securities identification number is: US42805E3062
What is Heska Corporation's CUSIP number?
Heska Corporation's Committee on Uniform Securities Identification Procedures number is: 42805E207

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site